On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Sang Biotech AB's own share of each project, not the project's full budget.
- Horizon Europe€325k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- TIE2getherPartner
Next-generation therapeutics for vascular diseases
Horizon Europe · 2027–2031 · Project on CORDIS ↗
€325ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- University College LondonUnited Kingdom · 1 shared project
- Helsingin YliopistoFinland · 1 shared project
- Uppsala UniversitetSweden · 1 shared project
- European Molecular Biology LaboratoryGermany · 1 shared project
- Charite - Universitaetsmedizin BerlinGermany · 1 shared project
- Universite Catholique de LouvainBelgium · 1 shared project
- Universitatsklinikum BonnGermany · 1 shared project
- Universidade Catolica PortuguesaPortugal · 1 shared project
- Cliniques Universitaires Saint-Luc ASBLBelgium · 1 shared project
- De Duve Institute AISBLBelgium · 1 shared project
- Biotechnology Research and Information Network AGGermany · 1 shared project
- Genevia Technologies OyFinland · 1 shared project
- Night Science Institute LTDUnited States · 1 shared project
- Belgian Vascular Anomaly Patient AssociationBelgium · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- glaucoma
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.